Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/29/20
End: 12/14/21
Due: 12/14/22
Phase: N/A
Priority: Normal
Start: 11/01/21
End: 11/01/22
Due: 11/01/23
Phase: N/A
Priority: Normal
Start: 07/13/21
End: 06/13/22
Due: 06/13/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers | NCT04688580 | XWPharma | user2@example.com | None | 2020-11-29 | 2021-12-14 | 2022-12-14 | - | - | 2025-07-14 |
| Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study | NCT05056194 | XWPharma | user2@example.com | None | 2021-11-01 | 2022-11-01 | 2023-11-01 | - | - | 2025-07-14 |
| Safety, Tolerability and Pharmacokinetics of XW10508 Immediate and Modified Release Formulations in Healthy Adults | NCT04966832 | XWPharma | user2@example.com | None | 2021-07-13 | 2022-06-13 | 2023-06-13 | - | - | 2025-07-14 |